Literature DB >> 857028

Ultrastructural comparison of differentiation of stem cells of murine adenocarcinomas of colon and breast with their normal counterparts.

G B Pierce, P K Nakane, A Martinez-Hernandez, J M Ward.   

Abstract

Two rats with chemically induced transplantable adenocarcinomas of the colon were given pulses of [3H]thymidine, and autoradiography with electron microscopes was used to compare the degrees of differentiation of the stem cells of the tumor and colon. The best differentiated portions of the tumor had acini composed of vacuolated, mucous, and argentaffin cells in various stages of differentiation. Vacuolated and mucous cells incorporated [3H]thymidine and corresponded in degree of differentiation to that of their labeled normal counterparts in the normal colon. An exceedingly undifferentiated labeled cell, hitherto undescribed, was identified in the tumor and crypts of the colon; this may be an undifferentiated colon stem cell that differentiates into vacuolated and mucous stem cells and/or into argentaffin cells. Normal stem cells of the breast and malignant stem cells of spontaneous adenocarcinomas of the breast of C3H mice had comparable degrees of differentiation. Since normal stem cells in these tissues were as undifferentiated as the least differentiated stem cells of the tumors, there is now no need to postulate dedifferentiation as a mechanism to explain the undifferentiated appearance of tumors.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 857028     DOI: 10.1093/jnci/58.5.1329

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  25 in total

1.  Cells immunoreactive for neuropeptide in human thymomas.

Authors:  L Lauriola; N Maggiano; L M Larocca; F O Ranelletti; R Ricci; M Piantelli; A Capelli
Journal:  J Clin Pathol       Date:  1990-10       Impact factor: 3.411

2.  The cancer cell and its control by the embryo. Rous-Whipple Award lecture.

Authors:  G B Pierce
Journal:  Am J Pathol       Date:  1983-10       Impact factor: 4.307

3.  Temporal morphologic changes in human colorectal carcinomas following xenografting.

Authors:  D H Barkla; P J Tutton
Journal:  Am J Pathol       Date:  1983-03       Impact factor: 4.307

Review 4.  Stem cell dynamics in homeostasis and cancer of the intestine.

Authors:  Louis Vermeulen; Hugo J Snippert
Journal:  Nat Rev Cancer       Date:  2014-06-12       Impact factor: 60.716

5.  Tumorigenicity of embryonal carcinoma as an assay to study control of malignancy by the murine blastocyst.

Authors:  G B Pierce; S H Lewis; G J Miller; E Moritz; P Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1979-12       Impact factor: 11.205

Review 6.  Stem cells and solid cancers.

Authors:  Stuart A C McDonald; Trevor A Graham; Stefanie Schier; Nicholas A Wright; Malcolm R Alison
Journal:  Virchows Arch       Date:  2009-06-05       Impact factor: 4.064

7.  Immune-induced epithelial to mesenchymal transition in vivo generates breast cancer stem cells.

Authors:  Marta Santisteban; Jennifer M Reiman; Michael K Asiedu; Marshall D Behrens; Aziza Nassar; Kimberly R Kalli; Paul Haluska; James N Ingle; Lynn C Hartmann; Masoud H Manjili; Derek C Radisky; Soldano Ferrone; Keith L Knutson
Journal:  Cancer Res       Date:  2009-03-10       Impact factor: 12.701

8.  Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity.

Authors:  L Vermeulen; M Todaro; F de Sousa Mello; M R Sprick; K Kemper; M Perez Alea; D J Richel; G Stassi; J P Medema
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-02       Impact factor: 11.205

Review 9.  The Emerging Picture of Human Breast Cancer as a Stem Cell-based Disease.

Authors:  César Cobaleda; Juan Jesús Cruz; Rogelio González-Sarmiento; Isidro Sánchez-García; Jesús Pérez-Losada
Journal:  Stem Cell Rev       Date:  2008       Impact factor: 5.739

10.  Transplantable acinar cell carcinoma of the rat pancreas.

Authors:  M S Rao; J K Reddy
Journal:  Am J Pathol       Date:  1979-02       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.